TrialClinical breast cancer2014

Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study.

Mark E Burkard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.